{
    "title": "J&J expects jump in COVID vaccine sales in 2022, eyes device deals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10439279/J-J-expects-3-5-bln-COVID-vaccine-sales-year.html",
    "date": "2022-01-25",
    "keywords": [
        "vaccine",
        "unit",
        "covid19",
        "revenue",
        "business",
        "forecast",
        "shot",
        "device",
        "jampjs",
        "street",
        "safety",
        "officer",
        "year",
        "inc",
        "time",
        "consumer",
        "health",
        "carl",
        "johnson",
        "jump",
        "stance",
        "uptake",
        "executive",
        "joaquin",
        "duato",
        "priority",
        "side",
        "history",
        "ceiling",
        "deal",
        "size",
        "call",
        "company",
        "covid",
        "target",
        "demand",
        "tool",
        "hardtoreach",
        "comparison",
        "partner",
        "biontech",
        "se",
        "moderna",
        "didnt",
        "contribution",
        "term",
        "analyst",
        "healthcare",
        "conglomerate",
        "abovemarket",
        "spot",
        "lot",
        "sense",
        "name",
        "mouthwash",
        "nonprescription",
        "half",
        "joseph",
        "wolk",
        "fourthquarter",
        "cancer",
        "drug",
        "imbruvica",
        "disease",
        "treatment",
        "stelara",
        "segment",
        "surge",
        "omicron",
        "variant",
        "hip",
        "knee",
        "abbvie",
        "jampj",
        "wall",
        "reporting",
        "bengaluru",
        "editing",
        "koyyur",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}